Trial to diagnose breast cancer more quickly
A scheme to let women with symptoms book an appointment directly with a clinic is being trialled.
Ozempic for all, Zepbound is back, and the top CEO pay: Pharma news roundup
The mayor of Rio de Janeiro is promising to make a generic version of Ozempic available through the city’s public health network — if he wins reelection. The top 5 highest-paid pharma CEOs all made over $60 million last year. And CVS Health Corporation (CVS) is set to slash 2,900 jobs as part of a multiyear, …Read more…
Fall River Eats: Galley Grille, Bally’s promos to help breast cancer care, research
Commercial AI tools can be used to predict breast cancer risk, need for extra screening
Researchers find tools developed for diagnosis can result in early detection of the disease, ensuring better prognosis Commercial artificial intelligence (AI) based tools developed for the detection of breast cancer can help early diagnosis of the disease, researchers have found. A breast-level AI score may be able to estimate the risk of future breast cancer
The post Commercial AI tools can be used to predict breast cancer risk, need for extra screening first appeared on Medibulletin.
The post Commercial AI tools can be used to predict breast cancer risk, need for extra screening appeared first on Medibulletin.
Study ties diabetes and obesity to increased risk of liver cancer relapse
Hepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal. Recent advances in antiviral therapy have reduced the number of patients affected, but obesity and diabetes are factors in hepatocellular carcinoma prevalence. However, these factors’ effects on patient survival and cancer recurrence have been unclear.
A mayor promises Ozempic for all and says there ‘will be no more fat people’ in his city
A Brazilian politician is making an interesting campaign pitch: Ozempic for all.Read more…
Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).Read more…
Balancing health: diabetes and obesity increase risk of liver cancer relapse
A research team analyzed how diabetes mellitus and obesity factor into recurrence and survival after surgery for hepatocellular carcinoma, a type of liver cancer.
TDXd Better Than Chemo for HER2-Low Breast Cancer?
Trial results suggested the antibody-drug conjugate may be a treatment option for patients with HER2 metastatic breast cancer in whom endocrine-based therapy has failed. Medscape Medical News
US breast cancer deaths fall but younger women increasingly diagnosed – study
Report shows significantly improved survival rates but a steep increase in disease among women younger than 50A new report from the American Cancer Society (ACS) finds that breast cancer deaths have dropped dramatically since 1989, averting more than 517,900 probable deaths.However, the report also reveals younger women are increasingly diagnosed with the disease, a worrying finding that mirrors a rise in colorectal and pancreatic cancers. Continue reading…